136 related articles for article (PubMed ID: 15363301)
1. [Application of sentinel lymph node biopsy by subareolar injection of blue dye in the treatment of breast carcinoma].
Xiao H; Li ZX; Chen X; Gong JZ
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):806-7. PubMed ID: 15363301
[TBL] [Abstract][Full Text] [Related]
2. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
3. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
4. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
5. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
Noguchi M; Inokuchi M; Zen Y
J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
7. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel node biopsy in gastric cancer.
Song X; Wang L; Chen W; Pan T; Zhu H; Xu J; Jin M; Finley RK; Wu J
Am J Surg; 2004 Feb; 187(2):270-3. PubMed ID: 14769318
[TBL] [Abstract][Full Text] [Related]
9. Blue-dye technique complements four-node sampling for early breast cancer.
Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
[TBL] [Abstract][Full Text] [Related]
10. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer].
Li JF; Ouyang T; Wang XJ; Wang TF; Xie YT; Fan ZQ; Lin BH; Yang Z; Lin BY
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):600-2. PubMed ID: 16784652
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
[TBL] [Abstract][Full Text] [Related]
13. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
[TBL] [Abstract][Full Text] [Related]
14. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
[TBL] [Abstract][Full Text] [Related]
15. [Sentinel lymph-node biopsy for breast cancer. Analysis of 235 cases and review of the literature].
Ballarin A; Franchini Z; D'Atri C; Marchi R; Tedeschi U
Chir Ital; 2006; 58(5):583-95. PubMed ID: 17069187
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of mastoscopic axillary sentinel lymph node biopsy].
Zhang J; Luo CY; Lin H; Xue L; Yang Q; Huang X; Zou RC; Zhang ZB; Zhou YQ; Ding Y; Pan BJ; Zhang SH; Li J
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):799-801. PubMed ID: 15363299
[TBL] [Abstract][Full Text] [Related]
18. Surmounting the challenges of sentinel lymph node biopsy for breast cancer in non-tertiary centres and community-based practices.
Tan MP
ANZ J Surg; 2006 May; 76(5):306-9. PubMed ID: 16768687
[TBL] [Abstract][Full Text] [Related]
19. Correlation between concordance of tracers, order of harvest, and presence of metastases in sentinel lymph nodes with breast cancer.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A; Ebihara S
Ann Surg Oncol; 2005 Jun; 12(6):497-503. PubMed ID: 15864480
[TBL] [Abstract][Full Text] [Related]
20. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping.
Gray RJ; Pockaj BA
Am J Surg; 2004 Oct; 188(4):423-5. PubMed ID: 15474440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
